TL
Telix Pharmaceuticals Limited
TLX · NASDAQ
$11.95 +0.17% (+$0.02)
1M -3.17%
Market Cap $5.95B
P/E Ratio -
Div. Yield -
ROE 1.68%
Bulios Fair Price
$11.05
7.5% downside
Trenutna cena
$11.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TLX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
8 /100
Expensive P/S 4.94x
P/B 9.57x
EV/EBITDA 81.73x
Growth
100 /100
Growing Book val. growth 98.13%
Rev. growth 96.00%
FCF growth N/A
Profitability
23 /100
Weak Net margin 0.89%
Op. margin 2.21%
FCF margin 6.87%
Quality
13 /100
Poor ROE 1.68%
ROA 0.60%
Asset turnover 0.68x
Debt
25 /100
High Current ratio 1.43x
Int. coverage 0.86x
Net debt/EBITDA 7.16x
Stability
26 /100
Unstable Rev. volatility 91.82%
EPS volatility 463.60%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christian Behrenbruch
Employees
1,152
Headquarters
North Melbourne
Prihajajoči dogodki
19 FEB.
Earnings
Upcoming earnings report